C&D, Abbott settle patent dispute
This article was originally published in The Tan Sheet
Abbott Labs will pay Church & Dwight $27 million to resolve allegations it infringed on three pregnancy diagnostic test kit patents, including two for "chemical analysis apparatus and method." The Sept. 17 settlement also says Abbott and device firm SurModics will not sue C&D for intellectual property infringement related to products that were the basis of a lawsuit. Abbott and SurModics must move to dismiss pending litigation against C&D, according to a Sept. 24 report C&D filed with the Securities and Exchange Commission. Abbott filed a 1complaint against C&D in June 2007, listing SurModics and Inverness Medical Switzerland as involuntary plaintiffs
You may also be interested in...
A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.
Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals.
Unfounded expectation some firms have for FDA to protect their investments in preparing successful NDI notifications is part of industry’s overall interest in increased regulation of the market, says Steven Tave, Office of Dietary Supplement Programs director.